Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.
Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Hulot JS, Arora S, Amoura Z, Piette JC, Costedoat-Chalumeau N; PLUS group. Jolly M, et al. Among authors: hulot js. Lupus. 2016 Jun;25(7):735-40. doi: 10.1177/0961203315627200. Epub 2016 Feb 13. Lupus. 2016. PMID: 26876692 Clinical Trial.
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
Costedoat-Chalumeau N, Hulot JS, Amoura Z, Leroux G, Lechat P, Funck-Brentano C, Piette JC. Costedoat-Chalumeau N, et al. Among authors: hulot js. Rheumatology (Oxford). 2007 May;46(5):808-10. doi: 10.1093/rheumatology/kel402. Epub 2007 Jan 3. Rheumatology (Oxford). 2007. PMID: 17202178
Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
Lenfant T, Salah S, Leroux G, Bousquet E, Le Guern V, Chasset F, Francès C, Morel N, Chezel J, Papo T, Cacoub P, Mouthon L, Guettrot-Imbert G, Cohen P, Régent A, Mauget-Faÿsse M, Piette JC, Jallouli M, Costedoat-Chalumeau N; PLUS Group. Lenfant T, et al. Rheumatology (Oxford). 2020 Dec 1;59(12):3807-3816. doi: 10.1093/rheumatology/keaa157. Rheumatology (Oxford). 2020. PMID: 32442312 Free PMC article.
[New insights and perspectives in the management of dyslipidemia].
Cohen Aubart F, Hansel B, Hulot JS, Lechat P, Bruckert E. Cohen Aubart F, et al. Among authors: hulot js. Rev Med Interne. 2007 Aug;28(8):537-44. doi: 10.1016/j.revmed.2007.01.022. Epub 2007 Mar 6. Rev Med Interne. 2007. PMID: 17337099 Review. French.
Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects.
Hulot JS, Wuerzner G, Bachelot-Loza C, Azizi M, Blanchard A, Peyrard S, Funck-Brentano C, Gaussem P. Hulot JS, et al. J Thromb Haemost. 2010 Mar;8(3):610-3. doi: 10.1111/j.1538-7836.2009.03729.x. Epub 2009 Dec 21. J Thromb Haemost. 2010. PMID: 20040040 Free article. Clinical Trial. No abstract available.
Clinical implications of neuropharmacogenetics.
Corvol JC, Devos D, Hulot JS, Lacomblez L. Corvol JC, et al. Among authors: hulot js. Rev Neurol (Paris). 2015 Jun-Jul;171(6-7):482-97. doi: 10.1016/j.neurol.2015.04.003. Epub 2015 May 23. Rev Neurol (Paris). 2015. PMID: 26008819 Review.
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity.
Scott SA, Collet JP, Baber U, Yang Y, Peter I, Linderman M, Sload J, Qiao W, Kini AS, Sharma SK, Desnick RJ, Fuster V, Hajjar RJ, Montalescot G, Hulot JS. Scott SA, et al. Among authors: hulot js. Clin Pharmacol Ther. 2016 Sep;100(3):287-94. doi: 10.1002/cpt.401. Epub 2016 Jun 20. Clin Pharmacol Ther. 2016. PMID: 27213804 Free PMC article.
297 results